January 19, 2018 / 6:03 AM / 8 months ago

BRIEF-BB Biotech to propose 3.30 Sfr dividend for 2017

Jan 19 (Reuters) - BB Biotech AG:

* SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER

* ‍UNDERLYING PORTFOLIO PERFORMED WELL, ENDING YEAR UP 23.4% IN CHF, 12.5% IN EUR AND 29.2% IN USD​

* ‍FULL YEAR 2017 DATA SHOWED A NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN FOR FULL YEAR 2016​

* ‍WILL PROPOSE A RECORD REGULAR DIVIDEND OF CHF 3.30 PER SHARE AT GENERAL ASSEMBLY ON MARCH 13, 2018​

* ‍BELIEVES THAT 2018 WILL CONTINUE TO BRING IMPORTANT PRODUCT APPROVALS AND MILESTONES FOR SECTOR AND FOR ITS PORTFOLIO​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below